logo
I stopped taking Mounjaro for 2 weeks & here's what really happens – yes, I've gained weight and I was ‘uncontrollable'

I stopped taking Mounjaro for 2 weeks & here's what really happens – yes, I've gained weight and I was ‘uncontrollable'

Scottish Sun08-07-2025
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
AFTER ditching Mounjaro for two weeks to go on holiday, a mother has shared what really happens when you stop taking fat jabs.
Carmel Elizabeth Smith, a mother from the UK, weighed 16 stone before she started using the injections in a bid to slim down.
Sign up for Scottish Sun
newsletter
Sign up
3
A mother has revealed what really happens when you stop taking Mounjaro
Credit: TikTok/mounjarojourneyandme2
3
Carmel Elizabeth Smith got candid on being 'uncontrollable' and shared exactly how much weight she put back on after ditching the injections for just two weeks
Credit: TikTok/mounjarojourneyandme2
3
Mounjaro is used to treat type 2 diabetes
Credit: Getty
Now, the pink-haired beauty, who was previously suffering from pre-diabetes and high cholesterol, has not only reversed these conditions, but has lost four stone and has dropped down to just 12 stone.
But Carmel was eager to set the record straight on what she has recently experienced after she stopped injecting.
Posting on social media, the savvy mum explained: 'So I went on holiday and didn't take Mounjaro for two weeks - I just wanna share what happened when I came off.
'For all the people thinking 'does the appetite come back?' Absolutely, absolutely.'
Mounjaro, which is known as the King Kong of jabs, is now being prescribed on the NHS in the first anti-obesity rollout of its kind.
It is said to suppress the ­appetite, making people feel fuller for longer.
Such injections are licensed for patients with type 2 diabetes and to assist those who are clinically obese - with a Body Mass Index of 30 or over.
One jab is administered each week but the duration is dependent on a person's weight.
But the content creator explained that she became 'uncontrollable' when it came to eating after stopping the injections, as she added: 'For the first five days on holiday, I was fine, I was just eating my normal little appetite - got to about day six and I started having some dinners, then it started to be little snacks in between.'
After two weeks, Carmel had put on 8lbs, as she explained: 'I got home and I don't know what happened, but I was uncontrollable - crisps, Haribo's, sweets, cake.'
Sun Health Explainer: Fat jabs
Now, Carmel is back on Mounjaro and luckily, is beginning to see her weight decrease again.
'Back on it and starting to lose again - but yeah, when you stop taking Mounjaro, God help," she confirmed.
Social media users react
Carmel's TikTok clip, which was posted under the username @mounjarojourneyandme2, has clearly left many open-mouthed, as at the time of writing, it had quickly racked up 223,700 views in just three days.
Not only this, but it had also amassed 1,158 likes and 315 comments.
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Social media users were stunned by Carmel's claims and many eagerly flocked to the comments to share their thoughts.
One person said: 'Thank you for this. I'm going away in a few weeks for two weeks and wasn't sure whether to stop or not but now I'm going to stay on it. For me personally, I'd rather eat a bit less on holiday as it's been so hard for me to lose weight over the last nine months. I'd be devastated if I ended up putting on weight while I was away.'
Another added: 'I'm thinking I'm gonna have to be on this for life.'
When you stop taking Mounjaro, God help
Carmel Elizabeth Smith
A third commented: 'I was fine for six weeks then bang…uncontrollable hunger.'
Whilst someone else wrote: 'I'd never ever stop, it's not worth it, I did it once because of finance but I'd never do it on purpose.'
Meanwhile, another user questioned: 'So does this mean you are trapped in the expensive money go round?'
To this, Carmel replied and confirmed: 'Looks that way.'
The reality of Mounjaro
Although many have boasted about weight loss success since using Mounjaro, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a fortnight.
A probe also found that nearly 400 people have gone to hospital after taking weight loss drugs.
The common side effects include nausea, vomiting and diarrhoea, which can lead to severe dehydration.
What are the other side effects of weight loss jabs?
Like any medication, weight loss jabs can have side effects.
Common side effects of injections such as Ozempic include:
Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts.
Vomiting: Can occur, often in conjunction with nausea.
Diarrhea: Some people experience gastrointestinal upset.
Constipation: Some individuals may also experience constipation.
Stomach pain or discomfort: Some people may experience abdominal pain or discomfort.
Reduced appetite: This is often a desired effect for people using Ozempic for weight loss.
Indigestion: Can cause a feeling of bloating or discomfort after eating.
Serious side effects can also include:
Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting.
Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon.
Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic.
Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic.
Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
And if that wasn't bad enough, doctors say they have also seen 'life-threatening complications', including seizures, bowel obstruction and inflammation of the pancreas.
Model Lottie Moss, 27, even said she had a seizure after taking high doses of Ozempic.
The makers of Mounjaro, Lilly UK, said patient safety is its 'top priority'.
Lilly UK stressed: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.
'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.'
Unlock even more award-winning articles as The Sun launches brand new membership programme - Sun Club
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Weight-loss jabs could help obese people control asthma, study suggests
Weight-loss jabs could help obese people control asthma, study suggests

South Wales Argus

time2 hours ago

  • South Wales Argus

Weight-loss jabs could help obese people control asthma, study suggests

The drugs should be explored as a potential treatment for obese people with the respiratory condition, who are 'often resistant' to steroids, researchers said. Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicing the hormone GLP-1 to regulate blood sugar and insulin levels. They were initially developed as a treatment for people with type 2 diabetes. A number of types of the drug are recommended to help tackle obesity on the NHS, including semaglutide, or Wegovy, and tirzepatide, or Mounjaro. Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international team of experts exploring their potential impact on obese people with asthma. Professor David Price, University of Aberdeen chair in primary care respiratory medicine, said: 'People with obesity and asthma are unique in that they are often resistant to steroid treatments. 'We know that GLP1s work on inflammatory responses in the airways in a different way to traditionally used steroids.' For the study, published in Advances in Therapy, researchers analysed the records of 10,111 people on GLP1-RAs and 50,555 people who were not on the drugs. After a follow-up period, the team found that those taking weight-loss jabs lost more weight and had improved asthma control. Researchers said the findings suggest medics 'should pay attention to the relationship between GLP-1 RA and the risk of respiratory diseases'. Prof Price added: 'We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms. 'In addition, it is important to note that the benefits to asthma symptoms occurred despite fairly modest weight loss of around 0.9kg over the course of the year. 'Our findings suggest that GLP1s may have beneficial effects on asthma control for people with obesity and this should be explored further.' Prof Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, said: 'Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs.' Dr Erika Kennington, head of research and innovation at Asthma and Lung UK, said: 'Research has previously shown that people living with obesity who lose weight see improved control of their asthma, so it's encouraging to see this study show this is still the case when the weight loss is driven by drugs, like the new class of weight loss drugs. 'Although exercise can help people lose weight, for some people it can cause anxiety about becoming breathless or having an asthma attack, so people are stuck in a vicious cycle of not being able to lose weight and their asthma worsening. 'Therefore, where exercise hasn't worked for someone these drugs that support weight loss could offer a promising alternative. 'It's too early to say whether these drugs would be effective for people with asthma more widely. 'More research is needed to understand how these drugs actually improve asthma control. Funding for lung health research is on life support and urgent action is needed to increase investment.'

ALISON BOSHOFF: Dragon's podcast gives ‘biased and dangerous' advice, says cancer expert
ALISON BOSHOFF: Dragon's podcast gives ‘biased and dangerous' advice, says cancer expert

Daily Mail​

time2 hours ago

  • Daily Mail​

ALISON BOSHOFF: Dragon's podcast gives ‘biased and dangerous' advice, says cancer expert

Dragons' Den star Steven Bartlett stands accused of spreading 'dangerous' misinformation on his latest Diary Of A CEO podcast. Bartlett, 32, hosted Dr Roger Seheult, a 'vitamin D expert', who he described as a 'world-leading doctor in internal medicine, lung health, critical care and sleep medicine'. In the trailer for the podcast, already viewed 4.5 million times, Dr Seheult describes a patient who was 'cured', miraculously, 'by sunlight'. Dr Seheult said: 'A 15-year-old boy was diagnosed with blood cancer but he developed a flesh-eating infection in his lung. He wasn't going to make it. So he had one request – to go outside. That's what they did. After the second day, the infection was 60-70 per cent gone. It became clear to me that sunlight has so many health benefits.' He added: 'For example, if you are closer to the window, you are discharged from hospital faster.' Broadcaster and retired surgeon Dr Liz O'Riordan was alarmed by the claims in the trailer. 'This is one of the current problems with podcasts – clips carefully edited to go viral with shocking statements.' She added: 'The clip implies that leaving ITU for sunlight can stop people dying – and yes, it is dangerous. 'The medical information this doctor tells us is second-hand – from the boy's mum, who is not a doctor – and we don't know what made her tell him this. But as a guy pushing sunlight, there will have been some bias in this interview.' (Coincidentally, a link on the podcast's social media offered listeners the chance to buy a sunlight lamp.) Dr O'Riordan, a breast cancer awareness campaigner diagnosed with the disease herself in 2015, said: 'Steven doesn't appear to challenge his guests or ask for the evidence.' She noted the study Dr Seheult mentions, about patients by windows being discharged earlier, was only a small trial, decades ago, of people being treated for bipolar disorder. Meanwhile, on TikTok, a video criticising the Dr Seheult episode of Diary Of A CEO (DOAC) has received more than 15,000 likes. Last year, the BBC World Service broadcast an investigation into Bartlett's podcast – the biggest in the UK, according to Spotify. It flagged that, in one episode, claims by cardiologist Aseem Malhotra that the 'Covid vaccine was a net negative for society' went unchallenged, allowing misinformation to be spread. (In response to the BBC investigation Dr Malhotra said he accepted people disagreed with his views but 'that does not mean that they have been debunked'.) The Lancet medical journal estimates that Covid-19 vaccines saved up to 1.5 million lives. The BBC highlighted other episodes, which aired claims that autism and schizophrenia could be caused by gluten, and that cancer can be 'managed' by food rather than 'medieval' chemotherapy. A spokesperson for Bartlett's production company, FlightStory Studio, said: 'Each guest episode is thoroughly researched prior to commission. DOAC offers guests freedom of expression and believes that progress, growth and learning comes from hearing a range of voices, not just those Steven and the DOAC team agree with.' Dr O'Riordan told me: 'Podcasts like this are a big-money business. The more shocking you can make the story, the more clicks you get. Podcasts are not regulated, people can – and do – say anything they like.' Bartlett said in 2024 he expected to make £20 million that year from his podcast. Adria steps in to ensure it's not the end of the Affair... The Thomas Crown Affair – telling the story of a millionaire who commits heists for the sheer hell of it, and falls for the insurance investigator who is on his tail – is so good they've made it three times. First, of course, was the 1968 classic with Steve McQueen and Faye Dunaway (pictured below) – and soundtrack featuring The Windmills Of Your Mind. Then it was remade in 1999, with Pierce Brosnan alongside Rene Russo. And now comes another reboot with actor, director and producer Michael B. Jordan, who is hot right now thanks to the success of the film Sinners. His version, slated to come out in 2027, started filming in London a couple of weeks ago, but within days the leading lady Taylor Russell stepped away from the movie, with sources saying that there were 'creative differences' between her and Jordan. Luckily, Adria Arjona has leapt into the breach. Arjona, who is stepping out with actor Jason Momoa, appears in the Disney Star Wars spinoff Andor, and also starred in Hit Man with Glenn Powell and Blink Twice with Channing Tatum. Big new role for Barbie star Margot TIM Burton is set to direct Margot Robbie in a remake of the 1958 cult classic Attack Of The 50 ft Woman. The trade papers report that Robbie is going to star in and produce the project, which has been in development at Warner Bros since early 2024. In the movie, an heiress has a close encounter with an alien spacecraft, causing her to grow to the size of a skyscraper. The original starred Allison Hayes, and there was a 1993 TV version which starred Darryl Hannah. Meanwhile, Burton's Wednesday – his series for Netflix about Wednesday Addams – has been commissioned for series 3. The second series comes out next month. $6,000 a ticket, Macca? This had better be good Fans may have been stunned by the price of tickets to see Taylor Swift during her Eras tour – but they ain't seen nothing yet. While some resales to see TayTay ran to $900, the price of seeing Sir Paul McCartney on the US leg of his Got Back tour has reached … $6,308 a head. Tickets went on sale this week and were quickly snapped up, only to appear on resale sites like Viagogo, StubHub and Ticketmaster. Some tickets in Nashville and Pittsburgh are running at more than $6,000 each, with tickets elsewhere ranging between $200 and $1,600. McCartney's management team were not available for comment. But his former publicist Geoff Baker deplored the mess, saying on Facebook: 'The drawback with allowing dynamic pricing at your gigs to raise the cost of a ticket to $1,600 is the huge pressure that you then put on yourself. 'Because if people are paying that much many will expect … not only the best show that they have ever seen, but the best show that you have ever given.' Stephen Mangan met his wife Louise Delamere on the set of a film called Offending Angels. Mangan, who presents The Fortune Hotel on ITV from August 6, said proudly: 'It's the lowest grossing film in British history and made £94 at the box office.' The film, released in 2000, also starred Andrew Lincoln and Jack Davenport. LA sources say that the plastic surgeon's most requested standard of modern beauty is ... Emily Ratajkowski, who plays a super-beautiful influencer in Lena Dunham's hit Netflix comedy Too Much. Apparently everyone wants her cheekbones and jawline. Another satisfied customer! I hear that Olympic diving champ-turned-TV fixture Tom Daley has left the agency YMU, following Claudia Winkleman, Amanda Holden, Emily Atack, Gabby Logan, Rob Rinder, Amelia Dimoldenberg and others out of the door. Football's NOT coming home! Ted Lasso is back – but this time nearly all the filming will be done outside the UK. The popular Apple TV+ show made a bit of a star of the London borough of Richmond, and also filmed around south London. But the latest series is being made mainly in ... Kansas City, where star Jason Sudeikis grew up. (Though it's still set in Richmond.) The new episodes will see Lasso start coaching a women's football team. Hannah Waddingham and Brett Goldstein are among the returning cast.

Weight-loss jabs could help obese people control asthma, study suggests
Weight-loss jabs could help obese people control asthma, study suggests

Rhyl Journal

time2 hours ago

  • Rhyl Journal

Weight-loss jabs could help obese people control asthma, study suggests

The drugs should be explored as a potential treatment for obese people with the respiratory condition, who are 'often resistant' to steroids, researchers said. Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicing the hormone GLP-1 to regulate blood sugar and insulin levels. They were initially developed as a treatment for people with type 2 diabetes. A number of types of the drug are recommended to help tackle obesity on the NHS, including semaglutide, or Wegovy, and tirzepatide, or Mounjaro. Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international team of experts exploring their potential impact on obese people with asthma. Professor David Price, University of Aberdeen chair in primary care respiratory medicine, said: 'People with obesity and asthma are unique in that they are often resistant to steroid treatments. 'We know that GLP1s work on inflammatory responses in the airways in a different way to traditionally used steroids.' For the study, published in Advances in Therapy, researchers analysed the records of 10,111 people on GLP1-RAs and 50,555 people who were not on the drugs. After a follow-up period, the team found that those taking weight-loss jabs lost more weight and had improved asthma control. Researchers said the findings suggest medics 'should pay attention to the relationship between GLP-1 RA and the risk of respiratory diseases'. Prof Price added: 'We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms. 'In addition, it is important to note that the benefits to asthma symptoms occurred despite fairly modest weight loss of around 0.9kg over the course of the year. 'Our findings suggest that GLP1s may have beneficial effects on asthma control for people with obesity and this should be explored further.' Prof Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, said: 'Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs.' Dr Erika Kennington, head of research and innovation at Asthma and Lung UK, said: 'Research has previously shown that people living with obesity who lose weight see improved control of their asthma, so it's encouraging to see this study show this is still the case when the weight loss is driven by drugs, like the new class of weight loss drugs. 'Although exercise can help people lose weight, for some people it can cause anxiety about becoming breathless or having an asthma attack, so people are stuck in a vicious cycle of not being able to lose weight and their asthma worsening. 'Therefore, where exercise hasn't worked for someone these drugs that support weight loss could offer a promising alternative. 'It's too early to say whether these drugs would be effective for people with asthma more widely. 'More research is needed to understand how these drugs actually improve asthma control. Funding for lung health research is on life support and urgent action is needed to increase investment.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store